India, Sept. 17 -- Alkem Laboratories on Wednesday announced the launch of NeuCeno (cenobamate) in India for the treatment of partial-onset seizures in adult patients.
The company said cenobamate is being introduced in India for the first time, where an estimated 94 lakh people are living with epilepsy. NeuCeno is a once-daily oral therapy available in tablet strengths ranging from 12.5 mg to 200 mg.
Published by HT Digital Content Services with permission from Dion Global Solutions Limited....